Growth Metrics

Boston Scientific (BSX) Total Non-Current Liabilities (2016 - 2026)

Boston Scientific's Total Non-Current Liabilities history spans 18 years, with the latest figure at $15.8 billion for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities changed 0.19% to $15.8 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $15.8 billion, a 0.19% change, with the full-year FY2025 number at $16.8 billion, up 6.61% from a year prior.
  • Total Non-Current Liabilities hit $15.8 billion in Q1 2026 for Boston Scientific, down from $16.8 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for BSX hit a ceiling of $35.3 billion in Q2 2024 and a floor of $10.1 billion in Q2 2022.
  • Historically, Total Non-Current Liabilities has averaged $21.1 billion across 5 years, with a median of $16.7 billion in 2025.
  • Biggest five-year swings in Total Non-Current Liabilities: plummeted 65.13% in 2022 and later surged 211.11% in 2023.
  • Tracing BSX's Total Non-Current Liabilities over 5 years: stood at $30.2 billion in 2022, then crashed by 54.79% to $13.6 billion in 2023, then grew by 15.51% to $15.8 billion in 2024, then increased by 6.61% to $16.8 billion in 2025, then dropped by 6.06% to $15.8 billion in 2026.
  • Business Quant data shows Total Non-Current Liabilities for BSX at $15.8 billion in Q1 2026, $16.8 billion in Q4 2025, and $16.7 billion in Q3 2025.